Takeda’s Dengue Vaccine Candidate Associated with Reduced Incidence of
Trial assesses safety and immunogenicity of different schedules of TAK-003 d...
2017-11-08
文传商讯
Takeda’s Dengue Vaccine Candidate Associated with Reduced Incidence of
Trial assesses safety and immunogenicity of different schedules of TAK-003 d...
2017-11-08
文传商讯
Takeda Completes Enrollment of More Than 20,000 Children and Adolescent
etravalent Immunization against Dengue Efficacy Study (TIDES) trial evaluate...
2017-04-13
文传商讯
Takeda Completes Enrollment of More Than 20,000 Children and Adolescent
etravalent Immunization against Dengue Efficacy Study (TIDES) trial evaluate...
2017-04-13
文传商讯
Takeda’s Dengue Vaccine Candidate Elicited Broad Immune Responses in C
- Analysis showed two doses of the vaccine candidate induced antibody respon...
2017-03-31
文传商讯
Takeda’s Dengue Vaccine Candidate Elicited Broad Immune Responses in C
- Analysis showed two doses of the vaccine candidate induced antibody respon...
2017-03-31
文传商讯
Takeda Initiates Global Phase 3 Clinical Trial (TIDES) of Dengue Vaccin
Study to evaluate vaccine protection against all four strains of dengue viru...
2016-09-09
文传商讯
Takeda Initiates Global Phase 3 Clinical Trial (TIDES) of Dengue Vaccin
Study to evaluate vaccine protection against all four strains of dengue viru...
2016-09-09
文传商讯
